IBRUTINIB + CHEMOIMMUNOTHERAPY (CIT) FOR RELAPSED/REFRACTORY MATURE B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL) IN CHILDREN (SPARKLE TRIAL): INITIAL SAFETY, PK, AND EFFICACY. (12th June 2019) - Burke, A.; Beishuizen, A.; Bhojwani, D.; Burkhardt, B.; Minard‐Colin, V.; Norris, R.; Kabickova, E.; Pinarli, F.; Tacyildiz, N.; de Jong, J.; Liu, G.; Howes, A.; et al.